Schuth Alexander O. — SEC Form 4 filings
SEC reporting owner CIK 1724311. 15 Form 4 filings on record with FilingPulse; latest filed 2026-09-03.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-01-09 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 16 legs across 10 filings — 99,941 shares, $2,082,649 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 12,333 shares @ $29.68 ($366,043) in Denali Therapeutics Inc., filed 2024-11-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Denali Therapeutics Inc. (DNLI) | COFO and Secretary | 15 | — | 16 legs · 99,941 sh · $2,082,649 | 12 |
Form 4 filings — Schuth Alexander O.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 2,768 @ $23.44 | EDGAR |
| 2026-08-13 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 2,857 @ $25.07 | EDGAR |
| 2026-01-08 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 17,218 @ $16.50 | EDGAR |
| 2026-01-05 | 4 | Denali Therapeutics Inc. (DNLI) | Grant/award (A): 57,700 @ $0 · Grant/award (A): 173,100 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 2,937 @ $13.58 | EDGAR |
| 2025-01-08 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 12,255 @ $20.22 · Sale (S): 2,907 @ $20.81 | EDGAR |
| 2025-01-07 | 4 | Denali Therapeutics Inc. (DNLI) | Grant/award (A): 54,180 @ $0 · Grant/award (A): 162,540 (derivative) @ $0 | EDGAR |
| 2024-12-31 | 4 | Denali Therapeutics Inc. (DNLI) | Option exercise (M): 6,708 @ $5.28 · Option exercise (M): 6,708 (derivative) @ $0 | EDGAR |
| 2024-11-26 | 4 | Denali Therapeutics Inc. (DNLI) | Option exercise (M): 20,516 @ $0.68 · Option exercise (M): 20,516 (derivative) @ $0 | EDGAR |
| 2024-11-12 | 4 | Denali Therapeutics Inc. (DNLI) | Option exercise (M): 15,558 @ $5.28 · Sale (S): 12,333 @ $29.68 · Sale (S): 2,925 @ $30.72 · Sale (S): 300 @ $31.29 · Option exercise (M): 15,558 (derivative) @ $0 | EDGAR |
| 2024-08-22 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 2,453 @ $23.79 · Sale (S): 3,353 @ $23.54 · Sale (S): 2,547 @ $24.78 | EDGAR |
| 2024-08-15 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 2,272 @ $22.89 | EDGAR |
| 2024-02-15 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 2,716 @ $17.29 · Sale (S): 20,128 @ $17.66 | EDGAR |
| 2024-02-12 | 4 | Denali Therapeutics Inc. (DNLI) | Option exercise (M): 50,000 @ $0.68 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2024-01-09 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 9,972 @ $19.43 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1724311 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →